Cyclin D1 and CDK4 contribute to breast tumorigenesis through their interaction with the cell cycle (3,4) and promote proliferation in endocrine-resistant breast cancer cells (5) and, together with Rb, potentially influence breast cancer pathogenesis and progression (3,4,6). This evidence concerns the gene RB1 and breast cancer.